Clustering of HIV-1 Subtypes Based on gp120 V3 Loop electrostatic properties

BMC Biophysics

Volumn 5, Issue 1, 2012, Pages

  López de Victoria, Aliana ^a   Kieslich, Chris A ^a   Rizos, Apostolos K ^b   Krambovitis, Elias ^c   Morikis, Dimitrios ^a  

^a University of California Riverside   (United States)

^b INSTITUTE OF ELECTRONIC STRUCTURE AND LASER   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Electrostatic clustering; Electrostatic similarity distance; HIV 1; Poisson boltzmann electrostatics; Protein receptor interactions

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84862187822     PISSN: 20461682     EISSN: None     Source Type: Journal    
DOI: 10.1186/2046-1682-5-3     Document Type: Article

References (78)

1. Emini EA, Koof WC. Developing and AIDS vaccine: need, uncertainty, hope. Science 2004, 304:1913-1914. 10.1126/science.1100368, 15218131.
2. Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Proc Natl Acad Sci USA 1998, 280:1884-1888.
3. Chan DC, Fass D, Berger JM, Kim PS. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997, 89:263-273. 10.1016/S0092-8674(00)80205-6, 9108481.
4. Krambovitis E, Porichis F, Spandidos DA. HIV-1 cell entry inhibitors: a new generation of antiretroviral drugs. ACTA Pharmacologica Sinica 2005, 26:1165-1173. 10.1111/j.1745-7254.2005.00193.x, 16174430.
5. Huang C, Tang M, Zhang MY, Majeed S, Montabana E, Stanfielg RL, Dimitrov DS, Korber B, Sodroski J, Wilson IA, Wyatt R, Kwong PD. Structure of a V3-containing HIV-1 gp120 core. Science 2006, 310:1025-28.
6. Huang C, Lam SN, Acharya P, Tang M, Xiang SH, Hussan SS, Stanfield RL, Robinson J, Sodroski J, Wilson IA, Wyatt R, Bewly CA, Kwong PD. Structures of the CCR5 N terminus and of a tyrosine sulfated antibody with HIV-1 gp120 and CD4. Science 2007, 317:1930-34. 10.1126/science.1145373, 2278242, 17901336.
7. Taylor BS, Sobieszczyk ME, McCuthan FE, Hammer SM. The challenge of HIV-1 subtype diversity. N Engl J Med 2008, 358:1590-1602. 10.1056/NEJMra0706737, 2614444, 18403767.
8. Dybowski JN, Heider D, Hoofman D. Prediction of co-receptor usage of HIV-1 from genotype. PLOS Comput Biol 2010, 6:e1000743. 10.1371/journal.pcbi.1000743, 2855328, 20419152.
9. Fouchier RAM, Groenink M, Kootstra NA, Termette M, Huisman HG, Meidema F, Shuitemaket H. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992, 66:3183-3187. 241084, 1560543.
10. Xiao L, Owen SM, Goldman I, Lal AA, deLong JJ, Goudsmit J, Lal RB. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinc global HIV-1 isolates: delineation of consesus motif in the v3 domain that predicts CCR5 usage. Virology 1998, 240:83-92. 10.1006/viro.1997.8924, 9448692.
11. Hung CS, Heyden NV, Ratner L. Analysis of the critical domain in the v3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization. J Virol 1999, 73:8216-8226. 112839, 10482572.
12. Cardozo T, Kimura T, Philpott S, Weiser B, Burger H, Zolla-Pazner S. Structural basis for coreceptor selectivity by the HIV type 1 v3 loop. AIDS Res Hum Retrov 2007, 23:415-426.
13. Seibert C, Cadene M, Sanfiz A, Chait BT, Sakmar TP. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotranferases 1 and 2 follows a discrete pattern and temporal sequence. Proc Natl Acad Sci USA 2002, 99:11031-11036. 10.1073/pnas.172380899, 123205, 12169668.
14. Farzan M, Vasilieva N, Schnitzler CE, Chung S, Robinson J, Gerard NP, Gerard C, Choe H, Sodroski J. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry. J Biol Chem 2000, 275:33516-33521. 10.1074/jbc.M007228200, 10938094.
15. Farzan M, Mirzabekov T, Kolchinsky P, Wyatt R, Cayabyab M, Gerard NP, Gerard C, Sodroski J, Choe H. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 1999, 96:667-676. 10.1016/S0092-8674(00)80577-2, 10089882.
16. Cormier EG, Persuh M, Thompson DAD, Lin SW, Sakmar TP, Olson WC, Dragic T. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120. Proc Natl Acad Sci USA 2000, 97:5762-5767. 10.1073/pnas.97.11.5762, 18507, 10823934.
17. Krambovitis E, Zafiropoulos A, Baritaki S, Spandidos DA. Simple electrostatic interaction mechanism in the service of HIV-1 pathogenesis. Scand J Immunol 2004, 59:231-234. 10.1111/j.0300-9475.2004.01377.x, 14871302.
18. Morikis D, Rizos AK, Spandidos DA, Krambovitis E. Electrostatic modeling of peptides derived from the V3 loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5. Int J Mol Med 2007, 19:343-351.
19. Baritaki S, Zafiropoulos A, Sioumpara M, Politis M, Spandidos DA, Krambovitis E. Ionic interaction of the HIV-1 v3 domain with CCR5 and deregulation T lymphocyte function. Biochem Biophys Res Comm 2002, 298:574-580. 10.1016/S0006-291X(02)02511-1, 12408990.
20. Tscherning C, Alaeus A, Fredriksson R, Björndal A, Deng H, Littman D, Fenyö EM, Albert J. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 1998, 241:181-188. 10.1006/viro.1997.8980, 9499793.
21. Heemelaar J, Gouws A, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006, 20:W13-W23. 10.1097/01.aids.0000247564.73009.bc, 17053344.
22. Spira S, Wainberg MA, Loemba H, Turner D, Brenner BG. Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemoth 2003, 51:229-240.
23. Korber B, Brander C, Haynes BF, Moore JP, Koup R, Walker BD, Watkins DI. HIV Molecular Immunology Database. Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, New Mexico., http://www.hiv.lanl.gov
24. Potts M, Halperin DT, Kirby D, Swidler A, Marseille E, Klausner JD, Hearst N, Wamai RG, Kahn JG, Walsh J. Reassessing HIV prevention. Science 2008, 320:749-750. 10.1126/science.1153843, 18467575.
25. Moore JP, Klasse PJ, Dolan MJ, Ahuja SK. A STEP into darkness or light?. Science 2008, 320:753-755. 10.1126/science.1154258, 18467578.
26. Walker BD, Burton DR. Toward an AIDS vaccine. Science 2008, 320:760-764. 10.1126/science.1152622, 18467582.
27. Kieslich CA, Yang J, Gunopulos D, Morikis D. Automated computational protocol for alanine scans and clustering of electrostatic potentials: application to C3d-CR2 association. Biotechnol Prog 2010, 27:316-325.
28. Kieslich CA, Gorham RD, Morikis D. Is the rigid-body assumption reasonable? Insights into the effects of dynamics on the electrostatic analysis of barnase-barstar. J Non-Cryst Solids 2010, 357:707-716.
29. Gorham RD, Kieslich C, Nichols A, Sausman NU, Foronda M, Morikis D. An evaluation of Poisson-Boltzmann electrostatic free energy calculations through comparison with experimental mutagenesis. Biopolymers 2011, 95:746-754.
30. Gorham RD, Kieslich C, Morikis D. Electrostatic clustering and free energy calculations provide a foundation for protein design and optimization. Ann Biomed Eng 2010, 39:1252-1263. 3069318, 21140293.
31. Hakkoymaz H, Kieslich CA, Gorham RD, Gunopulos D, Morikis D. Electrostatic similarity determination using multi-resolution analysis. Mol Inf 2011, 30:733-746.
32. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res 2000, 28:235-242. 10.1093/nar/28.1.235, 102472, 10592235.
33. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 1997, 18:2714-2723. 10.1002/elps.1150181505, 9504803.
34. Eswar N, Marti-Renom MA, Webb B, Madhusudhan MS, Eramian D, Shen M, Pieper U, Sali A. Comparative protein structure modeling with MODELLER. Curr Protoc Protein Sci 2007, 50:2.9.9-2.9.30.
35. Carbo R, Leyda L, Arnau M. How similar is a molecule to another? An electron-density measure of similarity between 2 molecular-structures. Int J Quantum Chem 1980, 17:1185-1189.
36. Hodgkin EE, Richards WG. Molecular similarity based on electrostatic potential and electric-field. Int J Quantum Chem 1987, 32:105-110.
37. Reynolds CA, Burt C, Richards WG. A linear molecular similarity index. Quant Struct-Act Rel 1992, 11:34-35.
38. Petke JD. Cumulative and discrete similarity analysis of electrostatic potentials and fields. J Comput Chem 1993, 14:928-933.
39. Blomberg N, Gabdoulline RR, Nilges M, Wade RC. Classification of protein sequences by homology modeling and quantitative analysis of electrostatic similarity. Proteins 1999, 37:379-387. 10.1002/(SICI)1097-0134(19991115)37:3<379::AID-PROT6>3.0.CO;2-K, 10591098.
40. Wade RC, Gabdoulline RR, Rienzo F. Protein interaction property similarity analysis. Int J Quantum Chem 2001, 83:122-127.
41. Wade RC, Gabdoulline RR, Ludemann SK, Lounnas V. Electrostatic steering and ionic tethering in enzyme-ligand binding: Insights from simulations. Proc Natl Acad Sci USA 1998, 95:5942-5949. 10.1073/pnas.95.11.5942, 34177, 9600896.
42. Schleinkofer K, Wiedemann U, Otte L, Wang T, Krause G, Oschkinat H, Wade RC. Comparative structural and energetic analysis of WW domain-peptide interactions. J Mol Biol 2004, 344:865-881. 10.1016/j.jmb.2004.09.063, 15533451.
43. Gabdoulline RR, Stein M, Wade RC. qPIPSA: Relating enzymatic kinetic parameters and interaction fields. BMC Bioinformatics 2007, 8:373. 10.1186/1471-2105-8-373, 2174957, 17919319.
44. Richter S, Wenzel A, Stein M, Gabdoulline RR, Wade RC. webPIPSA: a web server for the comparison of protein interaction properties. Nucleic Acids Res 36:W276-W280.
45. Stein M, Gabdoulline RR, Wade RC. Cross-species analysis of the glycolytic pathway by comparison of molecular interactions fields. Mol Biosyst 2010, 6:162-174.
46. Zhang XY, Bajaj CL, Kwon B, Dolinsky TJ, Nielsen JE, Baker NA. Electrostatic steering and ionic tethering in enzyme-ligand binding: insights from simulations. Multiscale Model Sim 2006, 5:1196-1213.
47. Kieslich C, Vazquez H, Goodman GN, López de Victoria A, Morikis D. The effect of electrostatics on Factor H function and related pathologies. J Mol Graph Model 2011, 29:1047-1055. 10.1016/j.jmgm.2011.04.010, 21605993.
48. El-Assaad AM, Kieslich CA, Gorham RD, Morikis D. Electrostatic exploration of the C3d-FH4 interaction using a computational alanine scan. Mol Immunol 2011, 48:1844-1850. 10.1016/j.molimm.2011.05.007, 21683447.
49. Gorham RD, Kieslich C, Morikis D. Complement inhibition by Staphylococcus aureus: electrostatics of C3d-EfbC and C3d-Ehp association. Cell Molec Bioeng DOI: 10.1007/s12195-011-0195-6.
50. Chae K, Gonong BJ, Kim SC, Kieslich CA, Morikis D, Balasubramanian S, Lord EM. A multifaceted study of stigma/style cysteine-rich adhesion (SCA)-like Arabidopsis lipid transfer proteins (LTPs) suggests diversified roles for these LTPs in plant growth and reproduction. J Exp Botany 2010, 61:4277-4290.
51. Cheung A, Kieslich C, Yang J, Morikis D. Solvation effects in calculated electrostatic association free energies for the C3d-CR2 complex, and comparison to experimental data. Biopolymers 2010, 93:509-519.
52. Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G, Baker NA. PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 2007, 35:W522-W525. 10.1093/nar/gkm276, 1933214, 17488841.
53. Sitkoff D, Sharp KA, Honig B. Accurate calculation of hydration free energies using macroscopic solvent models. J Phys Chem 1994, 98:1978-1988.
54. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 2001, 98:10037-10041. 10.1073/pnas.181342398, 56910, 11517324.
55. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 2004, 25:1605-1612. 10.1002/jcc.20084, 15264254.
56. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. ClustalW and ClustalX version 2. Bioinformatics 2007, 23:2947-2948. 10.1093/bioinformatics/btm404, 17846036.
57. Krambovitis E, Zafiropoulos A, Baritaki S, Spandidos D. Simple electrostatic interactions in the service of HIV-1 pathogenesis. Scand J Immunol 2004, 59:231-234. 10.1111/j.0300-9475.2004.01377.x, 14871302.
58. Krambovitis E, Spandidos DA. HIV-1 infection: is it time to reconsider our concepts?. Int J Mol Med 2006, 18:3-8.
59. Lu BZ, Zhou YC, Holst MJ, McCammon JA. Recent progress in numerical methods for the Poisson-Boltzmann equation in biophysical applications. Commun Comput Phys 2008, 3:973-1009.
60. Jain A, Mutty M, Flyn P. Data clustering: a review. ACM Comput Surv 1999, 31:264-323.
61. McCammon JA, Northrup SH, Allison SA. Diffusional dynamics of ligand-receptor association. J Phys Chem 1986, 90:3901-3905.
62. Sines JJ, Allison SA, McCammon JA. Point-charge distributions and electrostatic steering in enzyme substrate encounter - Brownian dynamics of modifies copper-zinc superoxide dismutases. Biochemistry 1990, 29:9403-9412. 10.1021/bi00492a014, 2248953.
63. Gabdoulline RR, Wade RC. Simulation of the diffusional association of barnase and barstar. Biophys J 1997, 72:1917-1929. 10.1016/S0006-3495(97)78838-6, 1184389, 9129797.
64. Gabdoulline RR, Wade RC. On the protein-protein diffusional encounter complex. J Mol Recogn 1999, 12:226-234.
65. Selzer T, Schreiber G. Predicting the rate enhancement of protein complex formation from the electrostatic energy of interaction. J Mol Biol 1999, 287:409-419. 10.1006/jmbi.1999.2615, 10080902.
66. Elcock AH, Sept D, McCammon JA. Computer simulation of protein-protein interactions. J Phys Chem B 2001, (105):1504-1518.
67. Spaar A, Dammer C, Gabdoulline RR, Wade RC, Helms V. Diffusional encounter of barnase and barstar. Biophys J 2006, (90):1913-1924.
68. Zhang L, Morikis D. Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics. Biophys J 2006, 90:3106-3119. 10.1529/biophysj.105.068130, 1432100, 16473914.
69. Zhang L, Mallik B, Morikis D. Immunophysical exploration of C3d-CR2(CCP1-2) interaction using molecular dynamics and electrostatics. J Mol Biol 2007, 369:567-583. 10.1016/j.jmb.2007.02.101, 17434528.
70. Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, Whitcomb JM, Young AM, Donnel D, Mmiro F, Musoke P, Guay LA, Jakson JB, Parkin NT, Petropoulos CJ. Coreceptor tropism in Human Immunodeficiency Virys type 1, subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral population. J Virol 2007, 81:7885-7893. 10.1128/JVI.00218-07, 1951291, 17507467.
71. Pollakis G, Kang S, Kliphuis A, Chalaby MIM, Goudsmit J, Paxton WA. N-Linked Glysosylation of the HIV Type 1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem 2001, 276:13433-13441. 10.1074/jbc.M009779200, 11278567.
72. Harrigan PR, Geretti AM. Genotypic tropism testing: evidence-based or leap of faith?. AIDS 2011, 25:257-264. 10.1097/QAD.0b013e32834113f9, 21099667.
73. Masso M, Vaisman II. Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage. BMC Bioinformatics 11:494.
74. Beerenwinkel N, Daumer M, Oette M, Korn K, Hoffmann D, Kaiser R, Lengauer T, Selbig J, Walter H. Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes. Nucl Acid Res 2003, 31:3850-3855.
75. Low AJ, Dong W, Chan D, Sing T, Swanstrom R, Jensen M, Pillai S, Good B, Harrigan PR. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates. AIDS 2007, 21:F19-F26.
76. Pillai S, Good B, Richman D, Corbeil J. A new perspective on V3 phenotype prediction. AIDS Res Hum Retrovir 2003, 19:145-149. 10.1089/088922203762688658, 12643277.
77. West R, Hawkins E, Jackson P. Preparation of modified cyanine dyes for the electrophoretic analysis of glycoproteins. 1999, In 6th International Conference on Methods and Application of Fluorescence: Spectroscopy, Imaging and Probes.
78. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graphics 1996, 14:33-38.